
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients
Tessa Gryp, Geert Huys, Marie Joossens, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 1986-1986
Open Access | Times Cited: 89
Tessa Gryp, Geert Huys, Marie Joossens, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 1986-1986
Open Access | Times Cited: 89
Showing 26-50 of 89 citing articles:
Association of the gut microbiome with kidney function and damage in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
Brandilyn A. Peters, Qibin Qi, Mykhaylo Usyk, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Brandilyn A. Peters, Qibin Qi, Mykhaylo Usyk, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Gut Microbiota Interventions to Retain Residual Kidney Function
Denise Mafra, Julie Ann Kemp, Natália Alvarenga Borges, et al.
Toxins (2023) Vol. 15, Iss. 8, pp. 499-499
Open Access | Times Cited: 14
Denise Mafra, Julie Ann Kemp, Natália Alvarenga Borges, et al.
Toxins (2023) Vol. 15, Iss. 8, pp. 499-499
Open Access | Times Cited: 14
Short-Chain Fatty Acids and Their Metabolic Interactions in Heart Failure
Laura Chulenbayeva, Argul Issilbayeva, Aliya Sailybayeva, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 343-343
Open Access
Laura Chulenbayeva, Argul Issilbayeva, Aliya Sailybayeva, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 343-343
Open Access
Odoribacter splanchnicus—A Next-Generation Probiotic Candidate
Jianhong Li, Jing Xu, Guo Xue, et al.
Microorganisms (2025) Vol. 13, Iss. 4, pp. 815-815
Open Access
Jianhong Li, Jing Xu, Guo Xue, et al.
Microorganisms (2025) Vol. 13, Iss. 4, pp. 815-815
Open Access
Role of gut–kidney axis in renal diseases and IgA nephropathy
Renato C. Monteiro, Laureline Berthelot
Current Opinion in Gastroenterology (2021) Vol. 37, Iss. 6, pp. 565-571
Closed Access | Times Cited: 29
Renato C. Monteiro, Laureline Berthelot
Current Opinion in Gastroenterology (2021) Vol. 37, Iss. 6, pp. 565-571
Closed Access | Times Cited: 29
Phosphate, Microbiota and CKD
Chiara Favero, Sol Carriazo, Leticia Cuarental, et al.
Nutrients (2021) Vol. 13, Iss. 4, pp. 1273-1273
Open Access | Times Cited: 28
Chiara Favero, Sol Carriazo, Leticia Cuarental, et al.
Nutrients (2021) Vol. 13, Iss. 4, pp. 1273-1273
Open Access | Times Cited: 28
Ameliorating effect of probiotics in a rat model of chronic kidney disease
Takio Inatomi, Mihoko Honma
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0281745-e0281745
Open Access | Times Cited: 12
Takio Inatomi, Mihoko Honma
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0281745-e0281745
Open Access | Times Cited: 12
Age‐dependent changes in the gut microbiota and serum metabolome correlate with renal function and human aging
Liang Sun, Zhiming Li, Caiyou Hu, et al.
Aging Cell (2023) Vol. 22, Iss. 12
Open Access | Times Cited: 12
Liang Sun, Zhiming Li, Caiyou Hu, et al.
Aging Cell (2023) Vol. 22, Iss. 12
Open Access | Times Cited: 12
Gut microbiota and kidney function in autosomal dominant polycystic kidney disease participants in Cameroon: a cross-sectional study
Inès Obolo Nwaga, Victorine Nzana, Rhoda Nsen Bughe, et al.
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access
Inès Obolo Nwaga, Victorine Nzana, Rhoda Nsen Bughe, et al.
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access
Influence du Microbiote Intestinal et de l'Axe Intestinal-Péritonéal sur la Dialyse Péritonéale – Revue de la littérature
Lucas Jacobs, Laura Mannie-Corbisier, Maxime Taghavi, et al.
Bulletin de la Dialyse à Domicile (2025) Vol. 8, Iss. 1, pp. 35-46
Open Access
Lucas Jacobs, Laura Mannie-Corbisier, Maxime Taghavi, et al.
Bulletin de la Dialyse à Domicile (2025) Vol. 8, Iss. 1, pp. 35-46
Open Access
Ketoanalogs’ Effects on Intestinal Microbiota Modulation and Uremic Toxins Serum Levels in Chronic Kidney Disease (Medika2 Study)
Maria Teresa Rocchetti, Biagio Di Iorio, Mirco Vacca, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 840-840
Open Access | Times Cited: 26
Maria Teresa Rocchetti, Biagio Di Iorio, Mirco Vacca, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 840-840
Open Access | Times Cited: 26
In Vitro Selection of Probiotics, Prebiotics, and Antioxidants to Develop an Innovative Synbiotic (NatuREN G) and Testing Its Effect in Reducing Uremic Toxins in Fecal Batches from CKD Patients
Mirco Vacca, Giuseppe Celano, Marcello Salvatore Lenucci, et al.
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1316-1316
Open Access | Times Cited: 25
Mirco Vacca, Giuseppe Celano, Marcello Salvatore Lenucci, et al.
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1316-1316
Open Access | Times Cited: 25
Roxadustat alleviates the inflammatory status in patients receiving maintenance hemodialysis with erythropoiesis-stimulating agent resistance by increasing the short-chain fatty acids producing gut bacteria
Xiu-Nan Zhao, Shuxin Liu, Zhenzhen Wang, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 10
Xiu-Nan Zhao, Shuxin Liu, Zhenzhen Wang, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 10
The Effect of Epimedium Isopentenyl Flavonoids on the Broiler Gut Health Using Microbiomic and Metabolomic Analyses
Jiaqi Zhang, Qingyu Zhao, Yuchang Qin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7646-7646
Open Access | Times Cited: 9
Jiaqi Zhang, Qingyu Zhao, Yuchang Qin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7646-7646
Open Access | Times Cited: 9
Iridoids modulate inflammation in diabetic kidney disease: A review
Tongyi Zhou, Na Tian, Liu Li, et al.
Journal of Integrative Medicine (2024) Vol. 22, Iss. 3, pp. 210-222
Closed Access | Times Cited: 3
Tongyi Zhou, Na Tian, Liu Li, et al.
Journal of Integrative Medicine (2024) Vol. 22, Iss. 3, pp. 210-222
Closed Access | Times Cited: 3
Production of Toxins by the Gut Microbiota: The Role of Dietary Protein
Lívia Alvarenga, Julie Ann Kemp, Beatriz G. Baptista, et al.
Current Nutrition Reports (2024) Vol. 13, Iss. 2, pp. 340-350
Closed Access | Times Cited: 3
Lívia Alvarenga, Julie Ann Kemp, Beatriz G. Baptista, et al.
Current Nutrition Reports (2024) Vol. 13, Iss. 2, pp. 340-350
Closed Access | Times Cited: 3
Investigation of the human-gut-kidney axis by fecal proteomics, highlights molecular mechanisms affected in CKD
Sonnal Lohia, Sophie Valkenburg, Rafael Stroggilos, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32828-e32828
Open Access | Times Cited: 3
Sonnal Lohia, Sophie Valkenburg, Rafael Stroggilos, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32828-e32828
Open Access | Times Cited: 3
Does the Composition of Gut Microbiota Affect Chronic Kidney Disease? Molecular Mechanisms Contributed to Decreasing Glomerular Filtration Rate
Ewelina Młynarska, Emilian Budny, Maciej Saar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10429-10429
Open Access | Times Cited: 3
Ewelina Młynarska, Emilian Budny, Maciej Saar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10429-10429
Open Access | Times Cited: 3
The Effects of Gum Acacia on the Composition of the Gut Microbiome and Plasma Levels of Short-Chain Fatty Acids in a Rat Model of Chronic Kidney Disease
Maha Al‐Asmakh, Muhammad Umar Sohail, Ola Al-Jamal, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 24
Maha Al‐Asmakh, Muhammad Umar Sohail, Ola Al-Jamal, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 24
Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease
Mieke Steenbeke, Sophie Valkenburg, Tessa Gryp, et al.
Toxins (2021) Vol. 13, Iss. 11, pp. 809-809
Open Access | Times Cited: 21
Mieke Steenbeke, Sophie Valkenburg, Tessa Gryp, et al.
Toxins (2021) Vol. 13, Iss. 11, pp. 809-809
Open Access | Times Cited: 21
Renal Health Improvement in Diabetes through Microbiome Modulation of the Gut–Kidney Axis with Biotics: A Systematic and Narrative Review of Randomized Controlled Trials
Pradipta Paul, Ridhima Kaul, Ali Châari
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14838-14838
Open Access | Times Cited: 15
Pradipta Paul, Ridhima Kaul, Ali Châari
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14838-14838
Open Access | Times Cited: 15
Aspartame, acesulfame K and sucralose- influence on the metabolism of Escherichia coli
Shayan Shahriar, Tamim Ahsan, Abira Khan, et al.
Metabolism Open (2020) Vol. 8, pp. 100072-100072
Open Access | Times Cited: 23
Shayan Shahriar, Tamim Ahsan, Abira Khan, et al.
Metabolism Open (2020) Vol. 8, pp. 100072-100072
Open Access | Times Cited: 23
Thrombolome and Its Emerging Role in Chronic Kidney Diseases
Justyna Fryc, Beata Naumnik
Toxins (2021) Vol. 13, Iss. 3, pp. 223-223
Open Access | Times Cited: 20
Justyna Fryc, Beata Naumnik
Toxins (2021) Vol. 13, Iss. 3, pp. 223-223
Open Access | Times Cited: 20
Indole and p-cresol in feces of healthy subjects: Concentration, kinetics, and correlation with microbiome
Francesco Candeliere, Marta Simone, Alan Leonardi, et al.
Frontiers in Molecular Medicine (2022) Vol. 2
Open Access | Times Cited: 13
Francesco Candeliere, Marta Simone, Alan Leonardi, et al.
Frontiers in Molecular Medicine (2022) Vol. 2
Open Access | Times Cited: 13
The modulation of gut microbiota by herbal medicine to alleviate diabetic kidney disease – A review
Jinxin Du, Meina Yang, Zhongwen Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Jinxin Du, Meina Yang, Zhongwen Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13